Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
adjunctive, adult, advocacy, aforementioned, aggravated, amenable, AMP, Amsterdam, angioedema, APPA, arbitrage, arrest, atmosphere, Ave, begun, beneficiary, BP, Britain, built, CA, cal, ceiling, chain, CJEU, clock, CMC, coadministration, Coast, Commissioner, corruption, CPRA, CTR, curb, cybersecurity, dance, database, degradation, departure, digital, disabled, disgorgement, dismissed, dispense, dispensed, display, displayed, disproportionate, distributor, DLT, draft, ECDRP, economy, edition, empower, encapsulated, endeavor, eosinophilic, epithelium, exact, exploit, FDCA, FIFO, fifteen, fold, formula, frame, freight, FSS, garnering, GPA, grace, granuloma, Guard, hacking, hearing, heavily, hepatotoxicity, highlighted, Homyk, hopping, HRSA, hypersensitivity, ID, immunogenicity, impossible, incurrence, Indian, infeasible, inflation, inpatient, Inspector, instructed, intentionally, intrusion, Justice, Labor, laid, language, lawfully, leukocyte, longevity, lowest, MDRP, membrane, MHLW, MHRA, military, Ministry, mission, misuse, motion, MPA, multicenter, nanomolar, Napoli, Neisseria, nose, notify, OIG, opposed, ordinary, outpace, overage, overcharge, overhead, Pan, parallel, pattern, payer, pediatric, penetration, perspective, pharmacy, phishing, piloting, PIP, plaintiff, PMC, PMR, pneumonia, portal, postmarketing, postpone, postponed, prioritization, prioritized, prompt, proper, purportedly, putative, recalculation, reconsider, regular, reluctance, remediation, rescinded, resell, resumed, retail, rural, sabotage, safest, Scotland, segregation, Senate, shareholder, Shield, signaling, simvastatin, skilled, sNDA, sophisticated, sophistication, statutorily, steady, store, streamlined, subgroup, sublicense, sublicensed, substrate, supervisory, tapering, theft, threshold, timetable, transformational, TRICARE, tunnel, uncollectible, underage, undetected, unlawful, unsatisfactory, untimely, unwilling, uptake, usage, VA, vigorously, Welfare, wholesale
Removed:
American, analogue, ATRA, Avenue, baseline, belong, Birmingham, black, box, brand, building, category, clear, clinic, comparative, compute, concretely, confer, contraindication, count, demonstrating, diagnosing, diarrhea, diverted, educational, eGFR, emergency, empaneled, enzyme, excellent, falling, FDASIA, financed, fistula, fulfilled, gap, glomerular, hepatic, histologic, imaging, impacted, improved, infusion, injection, inseverable, intact, Judge, led, LUMINA, mandate, Maude, mediating, mild, nausea, negotiated, neurodegenerative, numerically, onsite, opening, optional, peer, pill, progressive, pronounced, rapid, recommend, referenced, referencing, referendum, Relief, replicate, rulemaking, score, simplified, spending, statistically, sustaining, swallow, Taxpayer, urine, version, viral, visual, week, withdrew
Filing tables
Filing exhibits
Related press release
Associated CCXI transcripts
CCXI similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:
(1)
Registration Statements (Form S-3 Nos. 333-210731, 333-231257 and 333-239072) of ChemoCentryx, Inc.,
(2)
Registration Statement (Form S-8 No. 333-179507) pertaining to the ChemoCentryx, Inc. 2012 Equity Incentive Award Plan, the ChemoCentryx, Inc. Amended and Restated 2002 Equity Incentive Plan, the ChemoCentryx, Inc. Amended and Restated 1997 Stock Option/Stock Issuance Plan, and the ChemoCentryx, Inc. 2012 Employee Stock Purchase Plan, and
(3)
Registration Statement (Form S-8 No. 333-258671) pertaining to the ChemoCentryx, Inc. 2012 Equity Incentive Award Plan
of our reports dated March 1, 2022, with respect to the consolidated financial statements of ChemoCentryx, Inc. and the effectiveness of internal control over financial reporting of ChemoCentryx, Inc. included in this Annual Report (Form 10-K) of ChemoCentryx, Inc. for the year ended December 31, 2021.
/s/ ERNST & YOUNG LLP
Redwood City, California
March 1, 2022